FDA Grants Fast Track Designation for New Breast Cancer Treatment
The U.S. Food and Drug Administration (FDA) has released a new fast track designation for IDE161, an inhibitor of poly (ADP-ribose) glycohydrolase (PARG) to treat adult patients with advanced or […]